Key result
High PRECISE-DM score linked to ~3.2-fold higher risk of MACCE in asymptomatic diabetes.
Why the study?
Obstructive coronary artery disease is a significant predictor of adverse clinical events in asymptomatic patients with type 2 diabetes mellitus, prompting the development of an easy-to-use risk scoring system to predict it and long-term clinical outcome.
Does the PRECISE-DM risk score accurately predict obstructive coronary artery disease and MACCE in asymptomatic patients with type 2 diabetes mellitus?
Cohort (n=2,799)
Does the PRECISE-DM risk score accurately predict obstructive coronary artery disease and MACCE in asymptomatic patients with type 2 diabetes mellitus?
Hazard Ratio: 3.202 (95% CI 2.177–4.71)
Absolute Event Rate: 7.3% vs 2.3%
p-value: p=<.001
The PRECISE-DM risk score provides an easy-to-use tool with acceptable discrimination for predicting obstructive coronary artery disease and long-term MACCE in asymptomatic patients with type 2 diabetes.
May support MACCE risk stratification in asymptomatic T2DM; leaves open prospective validation before clinical adoption.
BACKGROUND: Obstructive coronary artery disease (OCAD) is a significant predictor of adverse clinical events in asymptomatic patients with type 2 diabetes mellitus (T2DM). HYPOTHESIS: We sought to develop an easy-to-use risk scoring system to predict OCAD and long-term clinical outcome in asymptomatic patients with T2DM (PRECISE-DM). METHODS: A total of 2799 asymptomatic patients with T2DM and no prior coronary disease were consecutively enrolled. OCAD was defined as ≥50% coronary artery stenosis on coronary computed tomography angiography (CCTA). A new risk scoring system was developed in 933 patients undergoing CCTA (derivation cohort) and its performance to predict OCAD and major adverse cardiac and cerebrovascular event (MACCE) was compared with other risk estimates. The scoring system was externally validated in 1899 patients not undergoing CCTA (validation cohort). RESULTS: The PRECISE-DM scoring system was created using seven variables that were associated with increased risk of OCAD, with scores ranging from 0 to 9. The scoring system predicted presence of OCAD with a C-statistic of 0.680 and risk of MACCE with a C-statistic of 0.708. The UKPDS risk engine and the Framingham risk score showed unreliable performance in prediction of OCAD (C-statistics 0.531 and 0.577, respectively). Calcium score was highly predictive for OCAD (C-statistic 0.825) but showed only modest accuracy in predicting MACCE (C-statistic 0.675). In the external validation cohort, the PRECISE-DM score showed acceptable discrimination for prediction of MACCE (C-statistic 0.707). CONCLUSIONS: The PRECISE-DM scoring system accurately predicted presence of OCAD and risk of MACCE in asymptomatic patients with T2DM.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2020) conducted a cohort in Type 2 diabetes mellitus without prior coronary disease (n=2,799). PRECISE-DM score ≥ 4 vs. PRECISE-DM score < 4 was evaluated on Major adverse cardiac and cerebrovascular events (MACCE) (HR 3.202, 95% CI 2.177-4.710, p=<.001). A PRECISE-DM risk score of ≥4 points in asymptomatic patients with type 2 diabetes was associated with a significantly higher risk of major adverse cardiac and cerebrovascular events (HR 3.202).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: